![]() |
市場調查報告書
商品編碼
2070371
男性乳房增大手術市場規模、佔有率、成長、全球產業分析、區域洞察及2026-2034年預測。Gynecomastia Procedures Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球男性隆乳手術市場預計在2025年達到4.818億美元,2026年成長至5.078億美元,2034年達到8.123億美元,預測期內複合年成長率(CAGR)為6.0%。男性隆乳手術旨在減少男性乳房組織增大,塑造更平坦、更具男性特徵的胸部輪廓。這些手術通常包括抽脂、腺體組織切除或兩者結合,這取決於乳房增大的原因是脂肪過多、腺體組織過多還是兩者兼有。
由於男性對整形手術的認知度不斷提高,對自身外表的關注度日益成長,以及男性對提升生活品質、增強自信和改善心理健康的需求不斷增加,男性整形市場持續成長。此外,肥胖、荷爾蒙失衡、藥物引起的乳房增大以及男性對整形手術接受度的提高也推動了市場擴張。預計到2025年,北美將以35.82%的市佔率引領全球市場。
男性乳房增大手術的市場趨勢
一個重要的市場趨勢是,以抽脂為中心的治療方法越來越受歡迎。目前,許多診所將抽脂作為主要治療方法,尤其是在男性女乳症伴隨脂肪組織過多的情況下。抽脂具有疤痕較小、乳房輪廓更美觀、恢復時間更短等優勢,必要時還可以與乳房切除聯合進行。這一趨勢與人們對微創美容手術的廣泛需求相吻合。
2024 年 1 月,Apyx 公佈了有關抽脂術後使用 Renuvion 的安全數據;2024 年 2 月,該公司推出了一項關於體型雕塑和抽脂應用的教育計畫。
市場促進因素
肥胖率上升和生活方式因素導致的荷爾蒙失衡是推動市場成長的關鍵因素。較高的體脂率會增加男性體內雌激素的活性,導致乳房增大。不良飲食、缺乏運動、飲酒、服用某些藥物也與男性女乳症的發生有關。隨著人們健康意識的提高,尤其是在注重外表和生活方式健康的都市區,越來越多的男性開始尋求醫療協助,而不是忽視這個問題。
市場限制因素
高昂的自費治療費用仍是一大障礙。由於男性女乳症手術通常被視為選擇性或美容手術,因此在許多地區,保險覆蓋範圍有限。患者通常需要承擔外科醫生諮詢費、麻醉費、手術室費用、術後護理費和復健費。這些費用可能會阻礙患者做出治療決定,尤其是在價格敏感地區以及那些認為手術並非必要的患者中。
市場機遇
微創塑形服務的擴展帶來了強勁的成長機會。醫療服務提供者越來越重視其快速恢復、更短的停工期、清醒狀態下進行的手術以及更先進的皮膚緊緻技術。這些優點使得男性女乳症治療對工作年齡層的男性更具吸引力。例如,AirSculpt計畫於2024年在哥倫布、迪爾菲爾德、伯明罕和懷特普萊恩斯擴建其塑形中心,以滿足日益成長的微創消脂和塑形服務需求。
市場挑戰
偏見和決策延遲仍然是市場面臨的重大挑戰。許多男性因為羞於啟齒或認為症狀會自然改善而避免尋求醫療建議。與其他美容手術不同,男性女乳症手術的決策週期往往較長,因為患者可能在尋求治療前多年一直隱藏症狀。此外,準確診斷至關重要,因為男性女乳症可能涉及脂肪、腺體組織或兩者兼有,因此需要進行切合實際的諮詢並制定個人化的治療方案。
區域分析
北美引領全球市場,預計2025年市場規模將達到1.726億美元,高於2024年的1.644億美元。這一成長主要得益於男性個人儀容意識的提高、肥胖率的上升以及美容手術的普及。預計到2026年,美國市場規模將達到1.559億美元,約佔全球銷售額的30.7%。
預計2026年,歐洲市場規模將達到1.542億美元,年複合成長率為5.5%。英國市場預計到2026年將達到2,590萬美元,德國市場預計將達到3,560萬美元。
受中國、印度和日本對醫療美容需求不斷成長的推動,亞太地區預計到2026年市場規模將達到1.358億美元。其中,中國市場規模預估為4,550萬美元,印度為3,050萬美元,日本為2,390萬美元。
預計到2026年,拉丁美洲市場規模將達到2,210萬美元,海灣合作理事會(GCC)市場規模預計為540萬美元。南非市場預計到2026年將達到220萬美元。
The global gynecomastia procedures market was valued at USD 481.8 million in 2025 and is projected to grow from USD 507.8 million in 2026 to USD 812.3 million by 2034, registering a CAGR of 6.0% during the forecast period. Gynecomastia procedures are performed to reduce enlarged male breast tissue and create a flatter, more masculine chest contour. These treatments generally include liposuction, gland excision, or a combination of both, depending on whether the enlargement is caused by excess fat, glandular tissue, or mixed tissue.
The market is growing due to increasing awareness of male aesthetic procedures, rising focus on physical appearance, and growing treatment demand among men seeking better comfort, confidence, and mental well-being. In addition, obesity, hormonal imbalance, medication-related breast enlargement, and wider acceptance of cosmetic surgery among men are supporting market expansion. North America dominated the global market in 2025 with a 35.82% market share.
Gynecomastia Procedures Market Trends
A major trend in the market is the growing adoption of liposuction-led treatment approaches. Many clinics now use liposuction as a primary method, especially when gynecomastia is linked to excess fatty tissue. Liposuction offers smaller scars, improved chest contouring, shorter recovery, and the option to combine with gland excision when required. This trend aligns with the broader demand for minimally invasive cosmetic procedures.
In January 2024, Apyx published safety data on Renuvion used after liposuction, while in February 2024 it promoted educational programs related to body contouring and liposuction applications.
Market Drivers
The rising prevalence of obesity and lifestyle-related hormonal imbalance is a key factor accelerating market growth. Higher body fat levels can increase estrogen activity in men, which may contribute to enlarged breast tissue. Poor diet, lack of exercise, alcohol consumption, and some medications are also linked to gynecomastia development. As awareness improves, more men are seeking medical consultation instead of ignoring the condition, especially in urban areas where aesthetic awareness and lifestyle-related health concerns are higher.
Market Restraints
High out-of-pocket treatment cost remains a major restraint. Gynecomastia procedures are often considered elective or cosmetic, so insurance coverage is limited in many markets. Patients must usually pay for surgeon fees, anesthesia, facility charges, post-operative care, and recovery-related expenses. These costs may delay treatment decisions, particularly in price-sensitive regions and among patients who view the procedure as non-essential.
Market Opportunities
The expansion of minimally invasive body contouring services is creating strong growth opportunities. Providers are increasingly promoting faster recovery, shorter downtime, awake procedures, and improved skin tightening technologies. These benefits make gynecomastia treatment more attractive to working-age men. For example, AirSculpt expanded its body contouring centers in 2024 across Columbus, Deerfield, Birmingham, and White Plains, supporting demand for minimally invasive fat removal and body shaping services.
Market Challenges
Stigma and delayed decision-making remain important market challenges. Many men avoid consultation due to embarrassment or the belief that the condition may improve naturally. Unlike some other cosmetic treatments, gynecomastia procedures often involve a long decision cycle, as patients may hide the condition for years before seeking treatment. Proper diagnosis is also important, as gynecomastia may involve fat, gland tissue, or both, requiring realistic counseling and personalized treatment planning.
Segment Analysis
By procedure type, the market is segmented into liposuction procedures, excision procedures, and others. The liposuction procedures segment is expected to hold the largest market share, as many cases involve excess fatty tissue. Liposuction supports smaller entry points, faster recovery, and better contouring results. The excision procedures segment is projected to grow at a CAGR of 5.6% during the forecast period.
By age group, the market is divided into 18-40 years and above 40 years. The 18-40 years segment dominated the market in 2025 due to stronger emphasis on appearance, fitness, body confidence, and social comfort. The above 40 years segment is expected to grow at a CAGR of 5.7%.
By indication, the market includes physiological gynecomastia, drug-induced gynecomastia, and others. Physiological gynecomastia dominated in 2025, as most cases are linked to natural hormone changes, obesity, puberty history, aging, or metabolic factors. The drug-induced gynecomastia segment is projected to grow at a CAGR of 5.6%.
By service provider, the market is divided into hospitals & ASCs, specialty cosmetic surgery clinics, and others. Specialty cosmetic surgery clinics held the highest market share in 2025 and are expected to account for 54.9% share in 2026, driven by strong expertise in male chest contouring and aesthetic procedures.
Regional Analysis
North America led the global market with USD 172.6 million in 2025, compared to USD 164.4 million in 2024. The region's growth is supported by high awareness of male aesthetics, rising obesity prevalence, and strong adoption of cosmetic procedures. The U.S. market is estimated at USD 155.9 million in 2026, representing around 30.7% of global sales.
Europe is projected to reach USD 154.2 million in 2026, growing at a CAGR of 5.5%. The U.K. market is estimated at USD 25.9 million in 2026, while Germany is expected to reach USD 35.6 million.
Asia Pacific is projected to reach USD 135.8 million in 2026, supported by growing medical aesthetics demand in China, India, and Japan. China is estimated at USD 45.5 million, India at USD 30.5 million, and Japan at USD 23.9 million in 2026.
Latin America is expected to reach USD 22.1 million in 2026, while the GCC market is projected at USD 5.4 million. South Africa is estimated at USD 2.2 million in 2026.
Competitive Landscape
The global market is semi-consolidated, with key players including The Plastic Surgery Clinic, Transform Hospital Group, Spire Healthcare Group plc, Nuffield Health, Apollo Cosmetic Clinics, Fortis Healthcare, VLCC Health Care Ltd., Kaya Limited, Bangkok Hospital Group, and Bumrungrad International Hospital. These providers are focusing on clinic expansion, advanced body contouring technologies, collaborations, and specialized male aesthetic services.
Key Industry Developments
In March 2026, Signature Clinic launched LipoForme, a dedicated U.K. clinic chain for liposuction and body contouring. In June 2024, BioZen updated its drug development program for gynecomastia treatment. In March 2024, Cleveland Clinic Abu Dhabi introduced an improved reconstructive procedure for gynecomastia outcomes. In June 2023, researchers associated with the American Society of Plastic Surgeons introduced a new affordable gynecomastia treatment.
Conclusion
The gynecomastia procedures market is expected to grow steadily from USD 481.8 million in 2025 to USD 507.8 million in 2026, reaching USD 812.3 million by 2034. Growth will be driven by rising obesity, hormonal imbalance, male aesthetic awareness, and demand for minimally invasive body contouring. Although high treatment costs and social stigma remain barriers, expanding specialty clinics and advanced liposuction-based procedures are expected to support strong market growth through 2034.
Segmentation By Procedure Type, Age Group, Indication, Service Provider, and Region
By Procedure Type * Liposuction Procedures
By Age Group * 18-40 Years
By Indication * Physiological Gynecomastia
By Service Provider * Hospitals & ASCs
By Region * North America (By Procedure Type, Age Group, Indication, Service Provider, and Country)